You may have heard about recent litigation involving birth control pills such as Yaz, Yasmin and Ocella. You may have also heard about Michelle Pfleger who, is an 18 year old college student, collapsed on her way to school. Michelle was rushed to an emergency room in a nearby hospital where eventually she died as a result of a blood clot. Her mother recently filed suit against Bayer charging that its birth control drug, Yaz, caused the blood clot that killed Michelle.
All birth control pills pose a risk of blood clots. However, studies published as recently as April 2011, found that the risk of blood clots for women who use birth control containing Drospierenone, which includes Yaz, Yasmin, Bayas, Safryle, Ocella and Gianvi, was two to three times higher than for women taking birth control pills containing some of the early generation contraceptives.
Recently, the CBS Early Show had an interview with Michelle’s mother on part of the safety of Yaz. Just before that show, the FDS announced that it is evaluated the risk of blood clots in women who use birth control pills that contain Drospierenone. The FDS’s announcement came after recent findings by the European Medicines Agency stating that it was updating its product information on oral contraceptives with Drospierenone on the risk on blood clots. If you, a loved one or a friend have experienced blood clots or injuries and have taken any of the above contraceptives please feel free to share your thoughts and comments with us.
- How Estate Planning for a Family May Trap the Unwary Practitioner - September 21, 2022
- What Everyone Should Know about the New FDIC Regulations - September 13, 2022
- The Inflation Reduction Act - September 8, 2022